Industry News
Sunshine Heart gets FDA tick for C-Pulse trial
Sunshine Heart (ASX:SHC) is set to commence a North American trial of its C-Pulse Heart Assist System, after receiving regulatory approval from the FDA. [ + ]
FDA clears AtCor blood pressure tool in US
AtCor Medical (ASX:ACG) has received FDA approval to market SphygmoCor XCEL, its upgraded cardiovascular diagnostics tool, in the US. [ + ]
Comment: Finding an alliance partner that will maximise the value of your assets
Marcus Bain, Managing Director of Wescadia Group gives a checklist for biotechnology companies of what to look for in a potential industry partner. [ + ]
Beat jetlag and sleep problems with new Australian invention
A new invention from Flinders University scientists can help reset the body clock, beat jetlag and allows shift workers to remain more alert and get more sleep. [ + ]
New Chief for CSIRO Land and Water
Australia’s environmental research will be significantly boosted by today’s appointment of internationally renowned scientist Professor Paul Bertsch as new Chief of CSIRO Land and Water. [ + ]
Waters selects MTM Research Center at Örebro University for Center of Innovation Honors
At a ceremony at the School of Science and Technology at Örebro University, Sweden, Waters has announced the selection of the MTM Research Center for its Centers of Innovation Program for research in the field of persistent organic pollutants (POPs) now regulated under provisions of the Stockholm Convention. [ + ]
Sirtex up on news of planned $4.5m manufacturing plant in Germany
Sirtex Medical (ASX:SRX) will invest $4.5m to build a manufacturing plant in Germany for its SIR-Spheres liver cancer treatments. [ + ]
Mesoblast gets go-ahead from FDA to manufacture stem cells
Mesoblast (ASX:MSB) and the US FDA have reached an agreement covering the company's manufacturing process for adult stem cells to be used in phase III trials. [ + ]
Food standards body calls for comment on cost recovery
Food Standards Australia New Zealand (FSANZ) invites comments on consultation papers it has released on proposed cost recovery arrangements for health claims applications. [ + ]
UNE scientist wins Young Tall Poppy Award
Dr Paul McDonald, a lecturer in animal behaviour at the University of New England, has been honoured with one of this year’s Young Tall Poppy Science Awards for NSW. [ + ]
Nanomedicine breakthrough improves chemotherapy for childhood cancer
In a world first, researchers from The University of New South Wales’ (UNSW) Australian Centre for NanoMedicine (ACN) have developed a nanoparticle that improves the effectiveness of chemotherapy for neuroblastoma by a factor of five. [ + ]
Getting to the heart of Prader-Willi Syndrome
Researchers at the Garvan Institute have found a sign that the rare genetic disorder, Prader-Willi Syndrome, is linked to problems in the autonomic nervous system. [ + ]
Mesoblast reaffirms Teva partnership following share slump
Mesoblast (ASX:MSB) has reassured shareholders of the strength of its partnership with Teva Pharmaceutical Industries after rumours circulated that Teva may exit the stem cell collaboration. [ + ]
Free pathology tests app launched for patients and doctors
Patients and their doctors can now get up-to-date information about pathology testing on their smartphones whenever and wherever they need it. [ + ]
LCT wins ethics nod for NZ Ntcell trial
Living Cell Technologies (ASX:LCT) has secured ethics approval for the first in-human trial of its Ntcell treatment in patients with Parkinson's disease. [ + ]
